Background. Several observational studies and randomized controlled trials (RCTs) have suggested an association between abacavir (ABC) use and myocardial infarction (MI) but others, including meta-analyses of clinical trial data, have not.
Comparison of Risk Category Predictions of Framingham Risk Score (FRS), Atherosclerotic Cardiovascular Disease Risk Score (ASCVD), Systematic Coronary Risk Evaluation (SCORE) and Data Collection on Adverse Events of Anti-HIV Drugs (D:A:D) in HIV Infected Patients
Methods. A cross-sectional study was conducted among adult HIV patients who are followed in five tertiary centers between July 2016 and February 2017. Inclusion criteria were: age 40-74 years, without known CVD and not receiving statins. All necessary information to calculate risk scores were collected during follow-up visits with a standardized form. Web-based tools for each score were used for calculations. Persons were considered at higher risk if 10-year CVD risks ≥20% with FRS-CVD, >10% with SCORE for high-risk countries, >7.5% for ASCVD, and 5 year risk ≥5% with DAD or if they had additional risk factors defined for each score for automatic high-risk stratification. Based on the interpretation of CVD risk, the patients were placed in two categories: low/medium and high/very high. Agreement between scores was assessed by Cohen's kappa (κ) statistics.
Results. Of 667 patients who were active during the study period, CVD scores of 527 HIV-infected patients (82% male) were assessed. Median (interquartile range) age was 48 (43-54) years. Prevalence of CVD risk factors were: 11% family history of early-onset CVD, 50% current smokers, 57% overweight or obese, 22% hypertension, and 8% diabetes mellitus. Background. Antiretroviral therapy (ART) associated dyslipidaemia has been reported among children living with HIV (CLHIV) in both developed and developing countries. Not much data is available on changes in blood lipid profile among CLHIV on first-line ART in India. Aims: To study the changes in the Lipid profile among CLHIVs, 12 months after initiating a non-nucleoside reverse transcriptase inhibitor-based (NNRTI) ART Methods. A prospective multicentric study enrolled HIV infected children, between 2-12 years of age, initiating NNRTI-based ART in south India. Clinical details, anthropometry and fasting blood for estimating serum total cholesterol (TC), triglyceride (TGL), high-density cholesterol (HDL-c), low-density cholesterol (LDLc), plasma viral load and CD4 cell counts was collected. These measurements were repeated at 6 th and 12 th month after ART initiation. Proportion of children with abnormal lipid profile at baseline and 12 months after ART were compared using McNemar test. Generalized linear model was applied to predict factors associated with changes in serum lipid levels 12 months post-ART.
Results. Of the 393 HIV-infected children, 66 % received Zidovudine and 14 % Stavudine in their ART regimen. After 12 months of ART, TC, LDL-c and HDL-c increased from baseline by a mean of 31mg/dL, 13.7 mg/dL and 19mg/dl, respectively. TC/HDL-c ratio decreased from a mean of 5.1 to 3.5 (all changes, P <0.000). At baseline and 12 months, respectively, TC was >200 mg/dL for 3% and 13% of patients, LDL-c was >130 mg/dL for 5% and 8%, HDL-c was <35 mg/dL for 70% and 16%, and TG were >150 mg/dL for 38% and 24%. Baseline HIV viral load >400 copies/mL (P, 0.01) was associated with increase in HDL-c and lower TG levels (P, 0.008). Baseline CD4 % <15 and younger age group were significantly associated with increase in TC (P, 0.02) and decrease in TGL (P,0.02) after 12-months of ART.
Conclusion. Significant changes in serum lipid profile occurs early in children started on first-line ART. Increase in the cardio protective HDL-c was proportionally greater than increases in TC or TGL. Regular monitoring of lipid levels will help in early identification of metabolic complications of ART Disclosures. All authors: No reported disclosures. Background. HIV-infected individuals are at increased risk for cardiovascular disease (CVD) compared with HIV-uninfected persons. CVD studies are typically conducted years after HIV diagnosis, however the impact of uncontrolled HIV replication and immune activation on cardiovascular health during early HIV infection has not been adequately studied.
Echocardiographic Assessment of US
Methods. All US Air Force members with HIV infection receive comprehensive medical evaluations to include cardiovascular assessment by screening transthoracic echocardiography (TTE). This retrospective study analyzed demographic, CVD, and HIV disease characteristics in all newly diagnosed USAF members evaluated between
